Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:CASNumber |
1802172-13-1
|
| gptkbp:clinicalTrialPhase |
Phase 1
Phase 2 |
| gptkbp:developedBy |
gptkb:Constellation_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
CPI-1205
|
| gptkbp:indication |
gptkb:cancer
gptkb:B-cell_lymphomas prostate cancer solid tumors |
| gptkbp:mechanismOfAction |
EZH2 inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
EZH2 inhibitor CPI-1205
|
| gptkbp:target |
gptkb:EZH2
|
| gptkbp:bfsParent |
gptkb:Constellation_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|